Peptide Nasal Sprays: Formulation Limits, Per-Actuation Maths and Storage

All a research peptide nasal spray amounts to is a solution of known concentration loaded into a metered-pump bottle — and the number that matters is not the total milligrams on the label but what a single actuation delivers, which is concentration multiplied by the pump's fixed stroke volume. The reason researchers use this route is anatomical: nasal mucosa is thin, richly supplied with blood vessels, and adjacent to trigeminal and olfactory pathways, which makes it the standard non-injected choice in intranasal delivery work. This page explains how such formulations are put together, what limits which peptides can be sprayed at all, how to calculate per-stroke mass, and how a liquid format deteriorates in comparison with lyophilized vials. Everything described relates to laboratory reference preparations.

The rationale for the intranasal route

A peptide that is swallowed encounters stomach acid followed by brush-border and pancreatic peptidases, and anything left is metabolised on first pass through the liver; for unmodified peptides, measured oral bioavailability is generally under 1% — the issue discussed in oral peptides, capsules and troches. The nasal cavity offers something quite different: roughly 150 cm² of thin, well-vascularised epithelium, considerably less proteolytic activity and no drainage through the portal vein. Intranasal studies on small peptides report bioavailabilities ranging from a few percent to the low tens of percent according to formulation and molecule — enormously better than the oral route, if still far from injection.

The second argument is also anatomical. From the 1990s onwards, work in rodents and non-human primates has described material placed on the olfactory epithelium moving along the perineural spaces of the trigeminal and olfactory nerves into brain tissue and cerebrospinal fluid, apparently bypassing the blood-brain barrier. This is why our nasal peptide sprays range is dominated by nootropic sequences: Semax, Selank and their relatives are exactly the molecules for which nose-to-brain transport is itself the object of study. The mechanism remains debated and human data thin, so it should be presented as reported rather than settled.

Constraints on sprayable peptides

• Molecular size. Absorption through nasal tissue falls away steeply past about 1,000 Da. Selank (751.89 Da) and Semax (813.93 Da) are comfortably under that threshold; a GLP-1 analogue at 4,113 Da is not, which is why the sprayed products in our range are all small peptides.
• Available volume. The cavity holds only about 100-150 µL before the surplus drains away, which is why metered pumps are built around a 0.1 mL stroke. If you need more peptide per stroke, increase the concentration — never the volume.
• Clearance. Mucociliary action carries deposited material back towards the nasopharynx within roughly 15-20 minutes, setting a ceiling on residence time no matter how the solution is formulated.
• Behaviour in water. Since a spray remains an aqueous solution at ambient temperature for weeks on end, the sequences most at risk are those with cysteine, methionine or Asn-Gly motifs, which are liable to disulfide exchange, oxidation or deamidation over that timescale.

Inside the bottle

Absorption enhancers — bile-salt derivatives, cyclodextrins, chitosan — appear frequently in the intranasal literature and can raise measured uptake several-fold, but they also cause more epithelial irritation in tissue models, which places them in the domain of formulation research rather than a general-purpose laboratory spray.

Working out what each stroke delivers

The nasal spray reconstitution kit supplies buffered diluent together with an empty 15 mL metered bottle; the calculation is yours to do.

1. Fix the concentration. Move a 10 mg vial of peptide into 10 mL of diluent and you have 1 mg/mL, i.e. 1,000 mcg/mL.
2. Apply the stroke volume. At 0.1 mL per actuation, one stroke carries 100 mcg (0.1 × 1,000).
3. Estimate the usable strokes. Dividing 10 mL by 0.1 mL suggests 100, but subtract the 3-5 used for priming plus the 0.5-1 mL that cannot be drawn from beneath the dip tube — plan on something like 85-90 rather than 100.
4. Change one variable. The same 10 mg in 5 mL instead gives 2 mg/mL, hence 200 mcg per stroke and about 42 usable actuations. Cutting the volume in half doubles what each stroke delivers and halves how long the bottle remains in service.

This is the same mg/mL calculation used for injectable stock solutions, and the reconstitution calculator will do it for you if you enter the bottle's volume in place of a vial's diluent volume. If you would rather not assemble the parts yourself, the nasal spray DIY kit pairs a 10 mg Semax vial with the bottle and solution.

Checking the pump instead of trusting it

A pump is specified at 0.1 mL, but individual units vary, and before priming the first few strokes deliver air or only part of a dose. The proper laboratory check is a weighing exercise: prime it five times, discharge ten strokes into a tared weighing boat, and divide the mass gained by ten. Aqueous solutions are close enough to 1 g/mL that 1.0 g over ten strokes verifies 0.1 mL per stroke. Repeat when roughly two-thirds of the contents have been used, because output per stroke falls once the dip tube starts to take in air.

How the liquid format ages

A freeze-dried vial contains dry solid and, kept frozen and dark, lasts years. A spray is the opposite in every respect: an aqueous solution, at room temperature, in a container with an opening and no septum. Every degradation route that matters for peptides — hydrolysis, deamidation, oxidation of methionine, disulfide exchange, and adsorption to the container surface — runs faster once the peptide is dissolved.

• Hold unopened sprays at 2-8 °C and warm them to room temperature before actuating; a cold solution is thicker and delivers a different volume per stroke.
• Keep the bottle refrigerated while in use as well. Preserved formulations tolerate room temperature, but it is the peptide rather than the preservative that sets the limit.
• Do not freeze a finished spray under any circumstances. Ice crowds solutes together at the advancing front and can crack the pump housing; how to store peptides discusses freeze–thaw damage to peptide solutions.
• Keep bottles standing upright and shielded from light, since tyrosine and tryptophan residues are sensitive to light — which is the reason opaque and amber containers are used.
• Treat a bottle in use as having weeks, not months, of useful life, and write the date of preparation on it. Log sheets and vial labels build that into your routine rather than relying on recollection.

Frequent errors

• Confusing the label mass with the delivered mass. A bottle marked 10 mg does not deliver 10 mg per stroke — each stroke is concentration × 0.1 mL.
• Ignoring priming losses when working out how much a bottle will yield.
• Preparing a spray in plain bacteriostatic water: sterile and preserved it may be, but it is unbuffered and hypotonic, so neither pH nor tonicity is controlled. Buffered nasal diluent exists for precisely this reason.
• Expecting a large peptide to work as a spray. Beyond roughly 1,000 Da, absorption in published models drops so far that spraying it becomes a study of delivery rather than a way of delivering.

The nasal spray FAQ covers formats, shelf life and shipping in more detail.